Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.

@article{Kibria2016AntitumorEV,
  title={Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.},
  author={Golam Mohammad Kibria and Hiroto Hatakeyama and Yusuke Sato and Hideyoshi Harashima},
  journal={International journal of pharmaceutics},
  year={2016},
  volume={509 1-2},
  pages={
          178-187
        }
}
Therapeutic Efficacy Evaluation of Pegylated Liposome Encapsulated With Vinorelbine Plus 111In Repeated Treatments in Human Colorectal Carcinoma With Multimodalities of Molecular Imaging
TLDR
The study proposed repeated treatments with a novel liposome-mediated radiochemotherapy and validation of therapeutic efficacy via imaging and suggested that tumor growth inhibition by 111In-VNB-liposome was significantly higher than that of the control.
Co-delivery of doxorubicin and the traditional Chinese medicine quercetin using biotin–PEG2000–DSPE modified liposomes for the treatment of multidrug resistant breast cancer
TLDR
In vivo antitumor activity studies demonstrated that DOX/QUE BPL could reach higher antitumors activity than other reference preparations for MCF-7/adr solid tumors and Histological assays indicated that this preparation could decrease the cardio toxicity arising from DOX and induce apoptosis in solid tumors.
Liposomal Nanoformulations as Current Tumor-Targeting Approach to Cancer Therapy
TLDR
The tumor-targeting mechanisms are described in detail as well as the possibilities to design the targeted liposomal nanocarrier in order to reach the desired target in the body and minimizing the off-target effects.
Manipulating the function of tumor-associated macrophages by siRNA-loaded lipid nanoparticles for cancer immunotherapy.
Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
TLDR
This review highlights recent studies using targeted nanoparticles for cancer treatment focusing on approaches that target either the tumor vasculature, the tumor microenvironment or the individual cancer cells (‘cellular targeting’).
Chapter 9 Liposomal Nanoformulations as Current Tumor-Targeting Approach to Cancer Therapy
TLDR
The tumor-targeting mechanisms are described in detail as well as the possibilities to design the targeted liposomal nanocarrier in order to reach the desired target in the body and minimizing the off-target effects.
Liposome-Based Drug Delivery for Lung Cancer
  • P. Skupin-Mrugalska
  • Biology
    Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer
  • 2019
...
...

References

SHOWING 1-10 OF 59 REFERENCES
Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy.
Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells.
TLDR
These findings show that DNCs not only provide an alternative route of delivery of doxorubicin to pgp-overexpressing cancer cells but also may boost the uptake of transferrin-tagged therapeutic agents.
Pegylated Liposomal Doxorubicin
TLDR
To conclude, pegylated liposomal doxorubicin is a useful option in the treatment of various malignancies, including metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi’s sarcoma.
Strategies to Increase Drug Penetration in Solid Tumors
TLDR
This chapter will review potential strategies to modulate the ECM and epithelial junctions to enhance the intratumoral diffusion and/or to remove physical masking of target receptors on malignant cells and provide examples that relaxin-based approaches increase the anti-tumor efficacy of oncolytic viruses, monoclonal antibodies, and T cells.
Pharmacokinetics of Pegylated Liposomal Doxorubicin
TLDR
The ability of pegylated liposomes to extravasate through the leaky vasculature of tumours, as well as their extended circulation time, results in enhanced delivery of liposomal drug and/or radiotracers to the tumour site in cancer patients.
A Cell-Targeted, Size-Photocontrollable, Nuclear-Uptake Nanodrug Delivery System for Drug-Resistant Cancer Therapy
TLDR
This work has used DNA self-assembly to develop a nuclear-uptake nanodrug system carried by a cell-targeted near-infrared (NIR)-responsive nanotruck for drug-resistant cancer therapy that can efficiently accumulated in the nuclei to effectively kill the cancer cells.
Comparative study of the sensitivities of cancer cells to doxorubicin, and relationships between the effect of the drug-efflux pump P-gp.
TLDR
This work demonstrated the way of exploring the factors mediating MDR in the tumor types without performing the analysis at the molecular level of cells by developing a correlation curve between the intracellular amounts of DOX and the sensitivities of cells.
Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma
TLDR
Encapsulation in liposomes containing surface‐bound PEG significantly limits the distribution and elimination of doxorubicin, results in greater accumulation of the drug in KS lesions 72 hours after dosing than does standard dox orubic in, and may improve drug efficacy and therapeutic index in the treatment of AIDS‐KS.
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.
TLDR
Increasing the molecular weight of dextran statistically significantly reduced its tumor vascular permeability and had the highest accumulation in solid tumors but were largely concentrated near the vascular surface.
...
...